Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Hartsough

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pigment Cell & Melanoma Research|November 2, 2016
αC IN, αC OUT-that's what it's all aboutEdward J Hartsough, Michael J Vido
The Journal of Investigative Dermatology|July 17, 2013
A STATement on vemurafenib-resistant melanomaEdward J Hartsough, Andrew E Aplin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
Of Mice and Melanoma: PDX System for Modeling Personalized MedicineEdward J Hartsough, Andrew E Aplin
Molecular Cancer Research : MCR|February 13, 2014
Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanomaEdward J Hartsough, Kevin J Basile, Andrew E Aplin
Molecular Cancer Research : MCR|October 2, 2020
Cell Adhesion Molecules in Plasticity and MetastasisJessica A Smart, Julia E Oleksak, Edward J Hartsough
Cell Reports|November 8, 2018
BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK AssociationMichael J Vido, Kaitlyn Le, Edward J Hartsough, et al.
Pigment Cell & Melanoma Research|January 16, 2014
Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitorsKevin J Basile, Kaitlyn Le, Edward J Hartsough, et al.
Cancer Metastasis Reviews|October 29, 2025
Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastasesCamille J Cunanan, Alyssa B Sanders, Kayla C Gallant, et al.
Cancer Research|July 19, 2014
Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitorCurtis H Kugel, Edward J Hartsough, Michael A Davies, et al.
Cancer Research|October 15, 2013
In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitorsKevin J Basile, Ethan V Abel, Neda Dadpey, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pigment Cell & Melanoma Research|November 2, 2016
αC IN, αC OUT-that's what it's all aboutEdward J Hartsough, Michael J Vido
The Journal of Investigative Dermatology|July 17, 2013
A STATement on vemurafenib-resistant melanomaEdward J Hartsough, Andrew E Aplin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
Of Mice and Melanoma: PDX System for Modeling Personalized MedicineEdward J Hartsough, Andrew E Aplin
Molecular Cancer Research : MCR|February 13, 2014
Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanomaEdward J Hartsough, Kevin J Basile, Andrew E Aplin
Molecular Cancer Research : MCR|October 2, 2020
Cell Adhesion Molecules in Plasticity and MetastasisJessica A Smart, Julia E Oleksak, Edward J Hartsough
Cell Reports|November 8, 2018
BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK AssociationMichael J Vido, Kaitlyn Le, Edward J Hartsough, et al.
Pigment Cell & Melanoma Research|January 16, 2014
Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitorsKevin J Basile, Kaitlyn Le, Edward J Hartsough, et al.
Cancer Metastasis Reviews|October 29, 2025
Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastasesCamille J Cunanan, Alyssa B Sanders, Kayla C Gallant, et al.
Cancer Research|July 19, 2014
Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitorCurtis H Kugel, Edward J Hartsough, Michael A Davies, et al.
Cancer Research|October 15, 2013
In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitorsKevin J Basile, Ethan V Abel, Neda Dadpey, et al.
Pageof 2